Biomarin Pharmaceutical Inc (BMRN)

Biomarin Pharmaceutical Inc (BMRN) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $10.8B; returns 1 day -1.2%, 1 week +2.3%, 1 year +2.6%.

BioMarin Pharmaceutical Inc. is a global biotechnology company that develops and commercializes innovative therapies for patients with serious and life-threatening rare genetic diseases.

Groups BMRN belongs to

• Shrinking Share Count
• Biotechnology
• Rare Diseases
• Pharmaceuticals
• Healthcare
• Commercial Stage Biotech
• Metabolic Disorders
• Life Sciences
• Biopharmaceutical
• Biologics

BMRN financial model: income statement, cash flow and balance sheet